Hong Kong University of Science and Technology
15
1
2
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 15 trials
100.0%
+13.5% vs industry average
13%
2 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Predictors of Clinical Outcomes of Deep Brain Stimulation in Parkinson's Disease
Role: lead
Artificial Intelligence-assisted MDS-UPDRS Assessment for Parkinson's Disease
Role: lead
Deciphering the Factors of Longevity Through a Multi-Omics Study in Long-Lived Individuals in Hong Kong
Role: lead
NeuroCare Community Project: A Community Based Prospective Observational Study for Early Alzheimer's Detection in HK
Role: lead
Evaluation of Trazodone in OSA-MCI
Role: collaborator
VR-based Multi-dimensional Intervention on Cognitive Function, With AI-agents
Role: lead
VR-based Physical Activity and Reminiscence Therapy
Role: lead
Co-design and Pilot Study in VR-based Physical Activity and Cognitive Training
Role: lead
Epigenetic Biomarkers for Alzheimer's Disease
Role: collaborator
Differentiating Between Brain Hemorrhage and Contrast
Role: collaborator
Large-scale COVID-19 Population Screening
Role: lead
Air Pollution (PM2.5) on Accelerated Atherosclerosis: A Montelukast Interventional Study in Modernizing China
Role: collaborator
Online Social Support Program for Physical and Mental Health of Filipino Migrant Domestic Workers in Hong Kong
Role: lead
A Multi-level Antimicrobial Surface Coating for a Healthier Environment
Role: lead
Source Profiling of Biohazardous Aerosols in Hospitals
Role: collaborator
All 15 trials loaded